Gastroenterology, Virginia Commonwealth University Health System, Richmond, Virginia, USA
Gastroenterology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
BMJ Open Gastroenterol. 2022 May;9(1). doi: 10.1136/bmjgast-2021-000778.
Liver transplantation (LT) is the only curative therapy in patients with end-stage liver disease. Long-term survival is excellent, yet LT recipients are at risk of significant complications. Biliary complications are an important source of morbidity after LT, with an estimated incidence of 5%-32%. Post-LT biliary complications include strictures (anastomotic and non-anastomotic), bile leaks, stones, and sphincter of Oddi dysfunction. Prompt recognition and management is critical as these complications are associated with mortality rates up to 20% and retransplantation rates up to 13%. This review aims to summarise our current understanding of risk factors, natural history, diagnostic testing, and treatment options for post-transplant biliary complications.
肝移植(LT)是终末期肝病患者唯一的治愈性治疗方法。长期生存率非常高,但 LT 受者有发生重大并发症的风险。胆道并发症是 LT 后的一个重要发病源,估计发病率为 5%-32%。LT 后的胆道并发症包括狭窄(吻合口和非吻合口)、胆漏、结石和 Oddi 括约肌功能障碍。及时识别和处理这些并发症至关重要,因为这些并发症与高达 20%的死亡率和高达 13%的再次移植率有关。本综述旨在总结我们目前对移植后胆道并发症的危险因素、自然病程、诊断检测和治疗选择的理解。